文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

纳米颗粒主要参数对其物理化学性质的影响及纳米药物递送系统在靶向化疗中的最新应用

Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.

作者信息

Zhang Jing, Tang Hua, Liu Zefa, Chen Baoan

机构信息

Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing.

Department of Hematology, People's Hospital of Xinghua City, Xinghua City, Jiangsu Province, People's Republic of China.

出版信息

Int J Nanomedicine. 2017 Nov 28;12:8483-8493. doi: 10.2147/IJN.S148359. eCollection 2017.


DOI:10.2147/IJN.S148359
PMID:29238188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5713688/
Abstract

Chemotherapy is still one of the main cancer therapy treatments, but the curative effect of chemotherapy is relatively low, as such the development of a new cancer treatment is highly desirable. The gradual maturation of nanotechnology provides an innovative perspective not only for cancer therapy but also for many other applications. There are a diverse variety of nanoparticles available, and choosing the appropriate carriers according to the demand is the key issue. The performance of nanoparticles is affected by many parameters, mainly size, shape, surface charge, and toxicity. Using nanoparticles as the carriers to realize passive targeting and active targeting can improve the efficacy of chemotherapy drugs significantly, reduce the mortality rate of cancer patients, and improve the quality of life of patients. In recent years, there has been extensive research on nanocarriers. In this review, the effects of several major parameters of nanoparticles on their physical and chemical properties are reviewed, and then the recent progress in the application of several commonly used nanoparticles is presented.

摘要

化疗仍然是主要的癌症治疗方法之一,但化疗的疗效相对较低,因此开发新的癌症治疗方法非常必要。纳米技术的逐渐成熟不仅为癌症治疗,也为许多其他应用提供了创新视角。有各种各样的纳米颗粒可供选择,根据需求选择合适的载体是关键问题。纳米颗粒的性能受许多参数影响,主要包括尺寸、形状、表面电荷和毒性。使用纳米颗粒作为载体实现被动靶向和主动靶向可以显著提高化疗药物的疗效,降低癌症患者的死亡率,并提高患者的生活质量。近年来,对纳米载体进行了广泛研究。在本综述中,回顾了纳米颗粒几个主要参数对其物理和化学性质的影响,然后介绍了几种常用纳米颗粒应用的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defa/5713688/76001aa632e6/ijn-12-8483Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defa/5713688/8f78cb51a417/ijn-12-8483Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defa/5713688/76001aa632e6/ijn-12-8483Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defa/5713688/8f78cb51a417/ijn-12-8483Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/defa/5713688/76001aa632e6/ijn-12-8483Fig2.jpg

相似文献

[1]
Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.

Int J Nanomedicine. 2017-11-28

[2]
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).

Recent Pat Anticancer Drug Discov. 2014-1

[3]
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Eur J Pharm Biopharm. 2015-6

[4]
Dendronized Systems for the Delivery of Chemotherapeutics.

Adv Cancer Res. 2018-5-18

[5]
An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.

Drug Res (Stuttg). 2016-11

[6]
Polymer- and liposome-based nanoparticles in targeted drug delivery.

Front Biosci (Schol Ed). 2010-6-1

[7]
Nanocarriers for cancer-targeted drug delivery.

J Drug Target. 2016

[8]
Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.

Curr Pharm Des. 2016

[9]
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.

Nanomedicine (Lond). 2010-11

[10]
Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.

Curr Drug Deliv. 2016

引用本文的文献

[1]
Trend analysis of reaction parameters and properties of plant-mediated green synthesized selenium nanoparticles using non-parametric statistical methods (Mann-Kendall trend test, Sen's slope estimator, ANOVA) and their applications in the modern world: a critical perspective.

RSC Adv. 2025-8-7

[2]
Developments in nanotechnology approaches for the treatment of solid tumors.

Exp Hematol Oncol. 2025-5-19

[3]
Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy.

Sci Rep. 2025-3-27

[4]
Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects.

ACS Pharmacol Transl Sci. 2025-1-23

[5]
- Challenges and Perspectives in Polyelectrolytes.

Biomacromolecules. 2025-1-13

[6]
Macrophage membrane coated discoidal polymeric particles for evading phagocytosis.

Biomed Eng Lett. 2024-6-12

[7]
Novel Kraft Softwood Lignin-Derived Carbon Quantum Dots: Synthesis, Characterization, and In Vitro Cytocompatibility.

Nanomaterials (Basel). 2024-6-13

[8]
Recent Advances in Targeted Therapies for Infantile Hemangiomas.

Int J Nanomedicine. 2024

[9]
Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024

[10]
Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles.

Bioact Mater. 2024-1-11

本文引用的文献

[1]
Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer.

Oncotarget. 2017-5-22

[2]
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial.

Eur J Cancer. 2017-8

[3]
General Approach of Stimuli-Induced Aggregation for Monitoring Tumor Therapy.

ACS Nano. 2017-6-22

[4]
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.

J Clin Invest. 2017-6-30

[5]
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma.

Mol Ther Nucleic Acids. 2017-6-16

[6]
Treatment outcome comparisons between exons 19 and 21 EGFR mutations for non-small-cell lung cancer patients with malignant pleural effusion after first-line and second-line tyrosine kinase inhibitors.

Tumour Biol. 2017-6

[7]
Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy.

Proc Natl Acad Sci U S A. 2017-6-12

[8]
Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer.

Int J Pharm. 2017-8-7

[9]
Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.

Cancer Chemother Pharmacol. 2017-8

[10]
Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.

Eur J Cancer. 2017-6-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索